about
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisTafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascadeTafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trialThe discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues.The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues.The increasing importance of genetic variation in drug discovery and development.Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy.
P50
Q26764754-588365D4-373E-4875-A3E8-1BE748DB64B3Q27679360-73E7C9E9-BE01-4C10-904D-D31EC715ACB0Q33903527-D023A578-EBD5-4BF3-A878-D60373485B9AQ34266647-8D97CC56-B563-4108-8979-4AE6E4DBD021Q34266654-B391F060-5C2A-4318-B301-0938DAB72323Q35069790-ED2A081F-18E5-4F51-B25C-E70544873FF4Q37301237-7584A9F9-11E4-4958-A239-A0B049178D01
P50
description
onderzoeker
@nl
name
Richard Labaudinière
@ast
Richard Labaudinière
@en
Richard Labaudinière
@nl
Richard Labaudinière
@sl
type
label
Richard Labaudinière
@ast
Richard Labaudinière
@en
Richard Labaudinière
@nl
Richard Labaudinière
@sl
prefLabel
Richard Labaudinière
@ast
Richard Labaudinière
@en
Richard Labaudinière
@nl
Richard Labaudinière
@sl